Global Periodontal Disease Therapeutics Market: Snapshot
Periodontal therapeutics are the non-surgical treatment for treatment of periodontal diseases. Periodontal disease is a chronic in?ammatory disease characterized by in?amed gingiva, bleeding on probing, resorption of alveolar bone and attachment loss between the tooth and its surrounding alveolar bone. According to American Academy of Periodontology the prevalence of periodontal disease is highest among ethnic minorities, with 63.5 percent of Hispanic-Americans, 59.1 percent of Non-Hispanic Blacks and 50 percent of Non-Hispanic Asian Americans.
Untreated periodontal disease results in chronic inflammation that leads to increased insulin resistance, reduced glucose tolerance, and an increased risk of diabetic complications. According to company Colgate-Palmolive, the number of people in the world with diabetes will approximate 300 million by the year 2025 and a large number of diabetic people in the world will be in emerging economies such as India and China.
According to Transparency Market Research, the global periodontal disease therapeutics market will exhibit a CAGR of 8.7% from 2016 to 2024, rising to a valuation of US$537.2 mn by 2024.
Local Antibiotics to Present More Promising Growth Opportunities
In terms of periodontal therapeutics products, the global periodontal therapeutics market has been segmented in the report into systemic antibiotics and local antibiotics. Of these, the segment of systemic antibiotics held a clear dominance, accounting for over 94% of the global market in 2016. The segment is expected to continue to remain at the top in terms of revenue contribution to the global market throughout the report’s forecast period, albeit with a slight decline as compared to its present share in the global market. Factors such as product affordability, availability, and high market penetration will continue to drive the demand for systemic antibiotics for the treatment of periodontal diseases.
The segment of local antibiotics is expected to lead in terms of growth rate over the forecast period, exhibiting a CAGR of 9.4% from 2016 to 2024. The vast advantages of local antibiotics such as fewer side effects, less chances of formation of resistant bacteria, direct local delivery, and 100 times greater concentration of antibiotics at the diseased site as compared to oral medication are likely to fuel the global demand for local antibiotics for the treatment of periodontal diseases.
North America to Continue Holding Dominant Share of Revenue of Global Market
In terms of geography, North America dominated the global periodontal therapeutics market, with a market share of over 40.0% in 2015. The high market share of North America in the global periodontal therapeutics market is attributed to factors such as the growing prevalence of periodontal diseases, new product innovation, favorable reimbursement scenario, and the rapidly rising geriatric population. According to Center for disease control and prevention, 47.2% of adults aged 30 years and older have some form of periodontal disease. This, coupled with the high awareness among the population will present vast growth opportunities for the periodontal disease therapeutics market in North America over the forecast period.
The Asia Pacific market is expected to dominate in terms of growth rate over the report’s forecast period. Factors contributing to the growth of the market include the rapid population growth, increasing diabetes patient pool, favorable healthcare insurance policies, and growing awareness among people. Surging medical expenditures in emerging economies such as India and China , growing government initiatives, rapidly rising healthcare R&D investment, and the presence of vast unmet medical needs will also drive the APAC periodontal therapeutics market over the forecast period. According to the National Commission on Macroeconomics and Health (NCMH), the prevalence of periodontal diseases in India was over 300 million in 2015. The prevalence is expected to rise in near future.
Some of the leading players operating in the global Periodontal Disease Therapeutics market are Valeant Pharmaceuticals international, Inc., 3M, Den-Mat Holdings, LLC Dexcel Pharma, and Galderma S.A.
Global Periodontal Therapeutics Market: Overview
Periodontal therapeutics are the non-surgical treatment procedure for treatment of periodontal disease. Based on the route of administration periodontal therapeutics are two types, such as local antibiotics and systemic antibiotics .The general purpose of local antibiotics is to reduce the number of bacteria present in the diseases periodontal pocket and the systemic antibiotics is to controlling bacterial infection. The report on global periodontal therapeutics market, analyzes the current and future prospects of the market. The report consists of an executive summary that provides information about the products, its segments and sub-segments, along with a market snapshot and comparative analysis by geography, in terms of revenue %, for 2015.
A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the periodontal therapeutics market, along with porter’s analysis, and value chain analysis, of the global market, has been provided in this report. Market revenue analysis for all the above mentioned segments, and their sub segments has been provided for the forecast period of 2016-2024, considering 2015 as the base year, and 2014 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2016-2024. Market share estimations were based on in-depth analysis and study of products, and their features, prices etc.
Global Periodontal Therapeutics Market: Scope of the Report
This report provides in-depth analysis of the periodontal therapeutics market. The stakeholders for this report include companies involved in the manufacturing of periodontal therapeutics. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition in different regions. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the periodontal therapeutics market. Furthermore, the report incorporates market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2015.
The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of Key Opinion Leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.
Global Periodontal Therapeutics Market: Segmentation
Based on product type, the global periodontal therapeutics market has been segmented into systemic antibiotics and local antibiotics. The systemic antibiotics segment is further categorized as doxycycline, minocycline, metronidazole and others. Others segment includes penicillin, amoxicillin etc. Local antibiotics are further segmented into Arestin and others. Based on end users, the market is segmented as hospitals pharmacies, retail pharmacies, drug stores and E-Commerce.
Based on geography, the market is segmented into North America, Europe, Asia Pacific and Rest of the World. The regions are further segmented into major countries which include, U.S., Canada, Germany, U.K., France, Italy, Spain, rest of Europe, China, Japan, India, Australia, and Rest of Asia Pacific. Rest of the world includes Latin America and Middle East & Africa. The report also comprises list major players in the market, their SWOT analysis, market share of these players in the periodontal therapeutics market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Valeant Pharmaceuticals international, Inc., 3M, Den-Mat Holdings, LLC Dexcel Pharma, Galderma S.A. among others.
The global periodontal therapeutics market has been segmented as follows:
Global Periodontal Therapeutics Market, by Product
- Systemic Antibiotics
- Local Antibiotics
Global Periodontal Therapeutics Market, by Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Drug Stores
Global Periodontal Therapeutics Diagnostics Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Middle East & Africa